AMN Healthcare
277 hedge funds and large institutions have $946M invested in AMN Healthcare in 2024 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 95 increasing their positions, 97 reducing their positions, and 96 closing their positions.
2% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 97
5% less call options, than puts
Call options by funds: $4.02M | Put options by funds: $4.24M
11.91% less ownership
Funds ownership: 115.79% → 103.88% (-12%)
15% less funds holding
Funds holding: 326 → 277 (-49)
47% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 96
49% less capital invested
Capital invested by funds: $1.86B → $946M (-$918M)
Top Buyers
| 1 |
NM
Newtyn Management
New York
|
+$37.7M |
| 2 |
WCM Investment Management
Laguna Beach,
California
|
+$17.5M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$16.8M |
| 4 |
RP
Reinhart Partners
Mequon,
Wisconsin
|
+$16.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14.5M |
Top Sellers
AMN Hedge Fund Activity: Q4 2024 in Review
277 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in AMN Healthcare (AMN) for Q4 2024, worth a combined $946M — down 49% from $1.86B a quarter earlier.
Sellers outnumbered buyers: 96 funds closed out of AMN and 51 opened new positions — a net loss of 45 holders — while 97 trimmed existing stakes and 95 added.
The largest buyer was Newtyn Management, opening a new position worth an estimated $37.7M. The largest seller was Fidelity Investments, cutting an estimated $52.3M.
- 277 institutional investors held AMN Healthcare (AMN) as of Q4 2024, down from 326 in Q3 2024.
- Funds reported $946M of AMN Healthcare stock for Q4 2024, down 49% quarter-over-quarter.
- 51 funds opened new AMN Healthcare positions in Q4 2024 and 96 closed out, a net change of -45 holders.
- The largest AMN Healthcare buyer in Q4 2024 was Newtyn Management, an estimated $37.7M added.
- The largest AMN Healthcare seller in Q4 2024 was Fidelity Investments, an estimated $52.3M sold.
Based on aggregated 13F filings for Q4 2024.